Ginseng
Ginseng is a pharmaceutical drug with 11 clinical trials. Historical success rate of 90.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
81.8%
9 of 11 finished
18.2%
2 ended early
0
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy of Ginseng for Patients on Regorafenib
Preventive Effects of Ginseng Against Atherosclerosis
A Clinical Trial of Ginseng in Diabetes
Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes
ROTEM and Dietary Supplements
Clinical Trials (11)
Efficacy of Ginseng for Patients on Regorafenib
Preventive Effects of Ginseng Against Atherosclerosis
A Clinical Trial of Ginseng in Diabetes
Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes
ROTEM and Dietary Supplements
Effect of Ginseng on Blood Pressure
Effect of American Ginseng on Exercise-induced Muscle Soreness
Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity
Korean Red Ginseng Rg3 Extract on Arterial Stiffness and Blood Pressure
Ginseng in Treatment of Fatigue in Multiple Sclerosis
Effects of Ginseng and Ginkgo on Drug Disposition in Man
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11